2,343
Participants
Start Date
October 31, 2007
Primary Completion Date
March 31, 2011
Study Completion Date
May 31, 2011
Peginterferon alfa-2a [Pegasys]
Peginterferon/ribavirin treatment period as prescribed by treating physician (e.g. 24 or 48 weeks) and treatment-free follow-up period of 24 weeks.
Peginterferon alfa-2b [PegIntron®]
Peginterferon/ribavirin treatment period as prescribed by treating physician (e.g. 24 or 48 weeks) and treatment-free follow-up period of 24 weeks.
Dublin
Dublin
Dublin
Brussels
Brussels
Brussels
Brussels
Brussels
Brussels
Antwerp
Antwerp
Edegem
Leuven
Genk
Liège
Seraing
Verviers
Namur
Godinne
Charleroi
Gilly (Charleroi)
Haine-Saint-Paul
Bruges
Sijsele
Ostend
Kortrijk
Roeselare
Tielt
Ghent
Aalst
Turin
Turin
Biella
Asti
Alessandria
Savona
Monza
Milan
Milan
Milan
Milan
Milan
Saronno
Busto Arsizio
Lecco
Treviglio
Brescia
Cremona
Novara
Venezia
Mestre (VE)
Treviso
Udine
Basovizza (TS)
Padua
Verona
Trento
Bolzano
Bologna
Parma
Ferrara
Florence
Arezzo
Grosseto
Fermo
Pescara
Castellana Grotte
Bisceglie
Foggia
Brindisi
Galatina
Casarano
Taranto
Nola
Gragnano
Napoli
Napoli
Napoli
Napoli
Napoli
Napoli
Napoli
Barra
Benevento
Isernia
Catanzaro
Vibo Valentia
Palermo
Catania
Comiso
Rome
Rome
Rome
Rome
Rome
Rome
Rome
Cagliari
Perugia
London
Hoffmann-La Roche
INDUSTRY